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Most clinicians are familiar with acanthosis nigricans, a 
dermatosis, characterised by brownish-black velvety, 
papilomatous hyperkeratotic plaques, usually occurring 
in the neck, axillae and other intertriginous surfaces.1 
Acanthosis nigricans is most frequently associated with 
insulin-resistant states, such as type 2 diabetes, polycystic 
ovarian disease and a variety of endocrine disorders.2 Less 
commonly, acanthosis nigricans is also associated with 
internal malignancies, such as carcinoma of the colon,3 
and in the setting of niacin use, in the management of 
dyslipidaemia.4 Acanthosis nigricans is detectable in more 
than 50% of children with type 2 diabetes mellitus, and 
is recognised more frequently in darker-skinned obese 
individuals.5 In this issue of JEMDSA, Venkatswami6 reports 
that the severity of acanthosis nigricans correlated with 
the degree of insulin resistance in a large group of Indian 
patients attending a dermatology clinic, and also with the 
texture of the lesions. Lesions that were rough to the touch 
or visibly coarse also correlated with the degree of insulin 
resistance, determined with homeostasis model assessment. 
Thus, acanthosis nigricans may be a useful sign when 
attempting to detect individuals at high risk of developing 
type 2 diabetes. It may be worthwhile investigating this 
finding in the South African context, especially in overweight 
and obese children and adolescents. 
Hypothyroidism in adults is associated with a decrease in 
red blood cell mass, usually manifesting as normochromic 
normocytic anaemia.7 Diminished oxygen requirements in 
hypothyroidism (and a resulting decrease in erythropoietin 
production)7 is the putative mechanism responsible 
for this finding. Less commonly, the anaemia may be 
macrocytic (due to associated vitamin B12
 deficiency or 
folate deficiency as a result of malabsorbtion or decreased 
intake), or microcytic (due to menorrhagia or decreased 
iron absorption as a result of achlorhydria in women of 
childbearing age).7 This traditional view was recently 
challenged by Kawa et al, who demonstrated that thyroid 
hormones directly modulate cell production in the bone 
marrow.8 Hypothyroidism and hyperthyroidism modifies 
thyroid receptor gene expression in haematopoietic 
progenitor cells in vivo. These authors also found that thyroid 
hormones strongly influenced the apoptotic process in 
haematopoietic progenitor cells by affecting the expression 
of pro- and anti-apoptotic genes. In this edition of JEMDSA, 
Onyiriuka et al9 describe severe persistent normochromic 
normocytic anaemia in a six-month-old Nigerian infant, 
eventually diagnosed with congenital hypothyroidism. The 
white cell and platelet count was not affected and the 
anaemia resolved with L-thyroxin replacement therapy. 
This case study demonstrates that anaemia may also be 
a clinical manifestation of hypothyroidism in paediatric 
patients. The finding of an umbilical hernia in an infant, 
as in this case, should alert the clinician to the need to 
investigate for hypothyroidism, and in so doing, prevent 
irreversible mental retardation.10,11  
In an important report, the World Health Organization (WHO) 
defines adherence (in the context of diabetes treatment) as 
the active and voluntary involvement of the patient in the 
management of his or her disease by following a mutually 
agreed course of treatment, and shared responsibility 
between the patient and healthcare providers.12 
Adherence (to self-care) is a complex phenomenon 
consisting of multiple domains, and is influenced by many 
factors, including socio-economic, healthcare systems, 
disease-specific, therapy-related and patient-related 
factors. According to the WHO report,12 poor adherence to 
treatment is prevalent in patients with diabetes, regardless 
of where the data were collected. Data from developing 
countries on prevalence and determinants of adherence 
are particularly scarce. Therefore, the qualitative study 
by Ebrahim, De Villiers and Tasneem,13 which reports on 
adherence to the dietary guidelines in the management 
of diabetes in this edition of JEMDSA, is of considerable 
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